BioCentury | Mar 14, 2019
Company News
Orphan Drug designation for Espero's long-acting anticoagulant
...once daily. Espero Biopharma Inc. (Jacksonville, Fla.) said the compound is Phase III-ready.
Elizabeth S. Eaton, Staff Writer
tecarfarin (ati-5923)
Espero Biopharma Inc.
Vitamin...
